For over a decade, pepducins have been utilized to develop unique pharmacological profiles that have been particularly challenging for traditional drug discovery methods. It is becoming increasingly clear that these cell-penetrating lipopeptides can access receptor conformations that are currently not accessible through orthosteric targeting. This review addresses the emerging concepts in the development of pepducins including the elicitation of biased signalling, pepducin polypharmacology and recent insight into their mechanism of action.
From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
Richard Carr, Jeffrey L. Benovic; From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins. Biochem Soc Trans 15 April 2016; 44 (2): 555–561. doi: https://doi.org/10.1042/BST20150230
Download citation file: